These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25825944)

  • 1. Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism.
    Zhang M; Tong G; Liu Y; Mu Y; Weng J; Xue Y; Luo Z; Xue Y; Shi L; Wu X; Sun S; Zhu Y; Cao Y; Zhang J; Huang H; Niu B; Li H; Guo Q; Gao Y; Li Z; Ning G; Zhu D; Li X;
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2449-55. PubMed ID: 25825944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of zinc supplementation in men with isolated hypogonadotropic hypogonadism.
    Liu YL; Zhang MN; Tong GY; Sun SY; Zhu YH; Cao Y; Zhang J; Huang H; Niu B; Li H; Guo QH; Gao Y; Zhu DL; Li XY;
    Asian J Androl; 2017; 19(3):280-285. PubMed ID: 27768007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
    Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
    Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
    Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
    Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group.
    Fertil Steril; 1998 Aug; 70(2):256-62. PubMed ID: 9696217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment preferences and outcome in male hypogonadotropic hypogonadism: an Indian perspective.
    Sanyal D; Chatterjee S
    Andrologia; 2016 Jun; 48(5):601-2. PubMed ID: 26341841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism.
    Burgués S; Calderón MD
    Hum Reprod; 1997 May; 12(5):980-6. PubMed ID: 9194651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
    Matsumoto AM; Karpas AE; Bremner WJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
    Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
    J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile GnRH Is Superior to hCG in Therapeutic Efficacy in Adolescent Boys With Hypogonadotropic Hypogonadodism.
    Gong C; Liu Y; Qin M; Wu D; Wang X
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2793-9. PubMed ID: 25978110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Hayes FJ; Dwyer A; Boepple PA; Lee H; Crowley WF
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4128-36. PubMed ID: 12213860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size.
    Burris AS; Rodbard HW; Winters SJ; Sherins RJ
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1144-51. PubMed ID: 3372679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.